~~<i id='9E5C45BB33'><strike id='9E5C45BB33'><tt id='9E5C45BB33'><pre id='9E5C45BB33'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

hotspot

author：explore 2025-10-01 12:54:43 - browse：45264

Two doctors operate a phone and a laptop next to stacks of cloud files — in the lab coverage from STAT — Adobe

Usually the words generative AI in health are followed by a bold claim. The technology will transform some aspect of care delivery, save gobs of money, or automate administrative tasks crucial to connecting patients with timely services.

Rohit Chandra, chief digital officer of the Cleveland Clinic, said generative AI can accomplish all these things. But he also said this:

“Harm is not just likely. It is for sure going to happen.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Surgeons perform first xenotransplant using CRISPR'd pig kidney

knowledge

explore

knowledge

hotspot

RyanPierse/GettyImagesHereisSTAT’sbiotechscorecard,ourregularledgerofstock-movingbiotechevents,forth

WSS

Prescription digital therapeutics are key to pharma’s future

This gene therapy has record $4.25 million price. It's saved children.

Canadians with cystic fibrosis outlive Americans by a decade

The wait for US passports is creating travel purgatory and snarling summer plans

Cancer, immunology, HIV research ensnared in fetal tissue politics

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

knowledge

hotspot

knowledge

Tori Bowie and the unacceptable rates of Black maternal death

CRISPR technology availability, affordability needs to be expanded

The high cost of giving birth even with insurance

Chinese researcher claims birth of first gene

Medical leaders decry Supreme Court decision on affirmative action

AstraZeneca lung cancer study comes in below expectations

Walensky prepares to leave CDC — and Congress — behind

Fatty liver disease was alleviated by Lilly’s ‘triple

The cancer drug shortage isn’t new — and neither are the solutions

Adam's Take: Intra

explore

STAT wants to know your pick for a great summer read or listen

Mirador, a new biotech startup, launches with $400 million

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

A letter from the executive editor: The 2023 STATUS List

Drug cartel violence flares in western Mexico after vigilante leader's killing

'Screen and refer' systems are hurting patients

knowledge

knowledge

hotspot

hotspot